Search

everythinglearnresearchcommunity

for

Search:↓

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Topical prostaglandin analogs may help with hair growth but more research is needed.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.